Publications by authors named "Mark Burkin"

Claim this Profile
E
Electromyographic Characteristics of Postactivation Effect in Dopamine-Dependent Spectrum Models Observed in Parkinson's Disease and Schizophrenia.
Alexander Meigal, Liudmila Gerasimova-Meigal, Anna Kuzmina, Elena Antonen, Alexandra Peskova, Mark Burkin

Biomedicines· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surface EMG parameters in schizophrenia patients.
German Miroshnichenko, Anna Kuzmina, Alexander Meigal, Mark Burkin, Saara M Rissanen

Annu Int Conf IEEE Eng Med Biol Soc· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationships between pharmacotherapy-induced metabolic changes and improved psychopathology in schizophrenia: data from a mirtazapine and first-generation antipsychotics combination trial.
Viacheslav Terevnikov, Jan-Henry Stenberg, Jari Tiihonen, Evgeni Chukhin, Marina Joffe, Mark Burkin

Int J Neuropsychopharmacol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors and mediators of add-on mirtazapine-induced cognitive enhancement in schizophrenia--a path model investigation.
Jan-Henry Stenberg, Viacheslav Terevnikov, Marina Joffe, Jari Tiihonen, Evgeny Chukhin, Mark Burkin

Neuropharmacology· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
More evidence on proneurocognitive effects of add-on mirtazapine in schizophrenia.
Jan-Henry Stenberg, Viatcheslav Terevnikov, Marina Joffe, Jari Tiihonen, Evgueni Tchoukhine, Mark Burkin

Prog Neuropsychopharmacol Biol Psychiatry· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Add-on mirtazapine improves depressive symptoms in schizophrenia: a double-blind randomized placebo-controlled study with an open-label extension phase.
Viacheslav Terevnikov, Jan-Henry Stenberg, Jari Tiihonen, Marina Joffe, Mark Burkin

Hum Psychopharmacol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
More evidence on additive antipsychotic effect of adjunctive mirtazapine in schizophrenia: an extension phase of a randomized controlled trial.
Viacheslav Terevnikov, Jan-Henry Stenberg, Marina Joffe, Jari Tiihonen, Mark Burkin

Hum Psychopharmacol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of add-on mirtazapine on neurocognition in schizophrenia: a double-blind, randomized, placebo-controlled study.
Jan-Henry Stenberg, Viatcheslav Terevnikov, Marina Joffe, Jari Tiihonen, Evgueni Tchoukhine, Mark Burkin

Int J Neuropsychopharmacol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Add-on mirtazapine enhances antipsychotic effect of first generation antipsychotics in schizophrenia: a double-blind, randomized, placebo-controlled trial.
Grigori Joffe, Viatcheslav Terevnikov, Marina Joffe, Jan-Henry Stenberg, Mark Burkin

Schizophr Res· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis